Diversified Healthcare Trust (NASDAQ:DHC) Stock Now Rated "Moderate Buy" by Wall Street Analysts

Key Points

• Diversified Healthcare Trust has a consensus “Moderate Buy” rating from six analysts, with an average 12-month price target of $9.83 versus a recent price of $7.96. Ratings range from sell to strong buy, reflecting mixed analyst views.
• Institutional investors own approximately 75.98% of DHC, with several major firms—including Bank of America, Dimensional Fund Advisors, and Arrowstreet Capital—recently increasing their holdings.
• DHC reported a quarterly loss of $0.16 per share, slightly worse than expectations, while revenue of $365.39 million also fell short of estimates. The REIT maintains a small quarterly dividend of $0.01 per share, equal to a 0.5% annualized yield.

Diversified Healthcare Trust (NASDAQ:DHC - Get Free Report) has earned an average rating of "Moderate Buy" from the six research firms that are presently covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation, two have given a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month target price among brokerages that have covered the stock in the last year is $9.83.

A number of equities analysts have issued reports on DHC shares. Maxim Group upped their target price on Diversified Healthcare Trust from $10.00 to $10.50 and gave the stock a "buy" rating in a report on Wednesday, June 3rd. Wall Street Zen raised Diversified Healthcare Trust from a "sell" rating to a "hold" rating in a research note on Saturday, August 8th. Royal Bank Of Canada boosted their price target on Diversified Healthcare Trust from $6.00 to $8.00 and gave the stock a "sector perform" rating in a report on Thursday, June 18th. Weiss Ratings reaffirmed a "sell (d-)" rating on shares of Diversified Healthcare Trust in a research note on Friday, July 17th. Finally, B. Riley Financial raised their price objective on shares of Diversified Healthcare Trust from $8.50 to $11.00 and gave the company a "buy" rating in a report on Tuesday, June 9th.

Institutional Trading of Diversified Healthcare Trust

Several institutional investors have recently modified their holdings of DHC. Dimensional Fund Advisors LP raised its position in Diversified Healthcare Trust by 6.1% during the 1st quarter. Dimensional Fund Advisors LP now owns 2,399,804 shares of the real estate investment trust's stock worth $15,935,000 after purchasing an additional 138,708 shares during the last quarter. Bank of America Corp DE lifted its holdings in Diversified Healthcare Trust by 90.4% during the 1st quarter. Bank of America Corp DE now owns 2,682,265 shares of the real estate investment trust's stock worth $17,810,000 after buying an additional 1,273,681 shares during the period. Amundi bought a new stake in shares of Diversified Healthcare Trust in the 1st quarter valued at about $847,000. Militia Capital Management LLC bought a new stake in shares of Diversified Healthcare Trust in the 1st quarter valued at about $1,422,000. Finally, Arrowstreet Capital Limited Partnership increased its stake in shares of Diversified Healthcare Trust by 30.7% in the first quarter. Arrowstreet Capital Limited Partnership now owns 2,354,824 shares of the real estate investment trust's stock valued at $15,636,000 after buying an additional 552,794 shares during the period. Institutional investors own 75.98% of the company's stock.

Diversified Healthcare Trust Stock Performance

NASDAQ DHC opened at $7.96 on Tuesday. The firm's fifty day moving average price is $8.26 and its two-hundred day moving average price is $8.18. The stock has a market cap of $1.93 billion, a PE ratio of -7.17 and a beta of 2.29. Diversified Healthcare Trust has a fifty-two week low of $3.92 and a fifty-two week high of $9.66. The company has a debt-to-equity ratio of 1.52, a quick ratio of 4.67 and a current ratio of 4.66.

Diversified Healthcare Trust (NASDAQ:DHC - Get Free Report) last announced its quarterly earnings results on Monday, August 3rd. The real estate investment trust reported ($0.16) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.15) by ($0.01). Diversified Healthcare Trust had a negative return on equity of 16.22% and a negative net margin of 17.73%.The company had revenue of $365.39 million for the quarter, compared to analyst estimates of $370.75 million. On average, equities analysts expect that Diversified Healthcare Trust will post 0.6 EPS for the current fiscal year.

Diversified Healthcare Trust Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, August 13th. Stockholders of record on Monday, July 20th were paid a dividend of $0.01 per share. The ex-dividend date of this dividend was Monday, July 20th. This represents a $0.04 annualized dividend and a dividend yield of 0.5%. Diversified Healthcare Trust's dividend payout ratio (DPR) is presently -3.60%.

About Diversified Healthcare Trust

Diversified Healthcare Trust NASDAQ: DHC is a real estate investment trust that owns and manages a diversified portfolio of healthcare-related properties across the United States. Its investments are intended to support the delivery of healthcare and related services while generating rental and other property income.

The company's portfolio includes medical office buildings, life science and research facilities, senior living communities, and other healthcare properties. These assets are generally leased to healthcare providers, senior living operators, life science companies, and other tenants, with property types and operating arrangements varying across the portfolio.

Diversified Healthcare Trust serves markets throughout the United States and has historically focused on properties that benefit from demand for healthcare services, aging-related housing, and medical research facilities.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.